Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

40%

2 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 3
2(66.7%)
N/A
1(33.3%)
3Total
Phase 3(2)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT05735106Completed

NC/TMD Ratio As a Difficult Airway Predictor in Obese Patients

Role: lead

NCT05751499Unknown

Diagnostic and Prognostic Blood Markers in Non Specific Low Back Pain

Role: collaborator

NCT05958277Phase 3Completed

Vitamin B12 vs B3 for Nerve Regeneration and Functional Recovery After Pediatric Traumatic Brain Injury

Role: lead

NCT05950061Phase 3Completed

Sertraline Versus Escitalopram in South Asian Participants With Moderate to Severe Major Depressive Disorder

Role: lead

NCT05469529Not ApplicableUnknown

Bupivacaine Alone vs Bupivacaine and Dexmed in Cesarean Deliveries

Role: lead

All 5 trials loaded